Member Info for Digger01

Maybe I should do the lottery this week.

I hope that this kicks off on schedule.
First DPI clinical trial in COPD patients expected to begin in December 2018;
secondly latest combination Ph2 trial due to report next month.
If successful, 2019 should be a pivotal year to take us into Ph3.
One day Rodders

Hope you and Rodi are well, and I am in the same boat as you know. However, I do believe that they are looking to cover all bases here with the intention of assessing all Ph2 data to best position before Ph3. I was in IMM and they went into Ph3 without enough preparation which has set them back, realistically 18 months and another likely fund raise to fund a likely new P3. I still have faith here and the strategy looks good. We are building a very strong case here, but any Ph3 MUST meet the end point. Many credible II's obviously believe. GL all LTH

This is very much linked to POG and POS.
However we seem to have a daily battle between east and west, am/pm. Eastern market gain, followed by the usual US pm hammering. Buy late pm and sell 1p the next day. Would have done very well of late. Unfortunately I don't have the time to do this or the risk appetite. I just lose as a LTH for now.!

Sorry but I don't read or post very often here but have 20k shares.
How do I get involved!

Izstar, I firmly believe that they want it to themselves and are not prepared to accept a deal not worth taking. I could be wrong but the last raise was huge and not just a token gesture to demonstrate financial stability to tie them over.

Nice to see you hanging in there as I know that we have both been in this boat for an unfortunately long time. I still believe that they want the Hospital after care market in the US on their own or partnership on that element only. Can't see a take out. Looks like it's going to be another year before any real action.

Thank you for your help, much appreciated.

Can anyone advise if it's possible to buy any products containing the LPldl Cholesterol lowering?

6p average so yes still 50% down and require a further 100% gain to break even. So all or nothing.

I still see them going alone with the Nebuliser option phase 1 in supporting post hospital care in the US. This would generate excellent revenue to support inhaler development. Possibly a joint venture of some kind, but I can't see any big boys taking his as they have had many opportunities to do so over the last 9 years! Still, things are hitting up and the SP has already risen 40% but only 3p old money and still 100% down for me. GL all LTH's

This is why they never have any problems raising money, the last of which was over 100m. These big investors are obviously all mugs. JAK a gold medal in convincing big investors. All those who believe we are dead, why not sell and recoup something? Anyway, as per the previous post, just my opinion. In saying this it has been a long long frustrating ride. Win or lose all for me I'm afraid

Anticipation of good trial results early Q1. The team said they are fast tracking the nebuliser option. It appears to be happening as the trials have been brought forward.

Like many LTH's on this board, experiencing years of promises with no delivery in terms of revenue / deals / partnerships etc..... Now many are becoming board, sceptical and losing any confidence. However, the science has never failed and every trial a success. No problem raising money against, the latter being huge! The main drive for sometime now, has been to address US after hospital care to reduce re-admissions for COPD us in the Nebuliser. A big market which IMHO they will support and go for themselves, not giving anything away. Longer term who knows, I believe these guys and big investors know exactly what they are doing and I don't see anything that will make me think otherwise at this point. However it has been a very very long painful and frustrating ride. Hang in there!

Thank you for the update. At least the SP decline is not down to selling due to the water crisis.

Presumably they use water in the processing and South Africa is in a desperate situation. Can anyone more informed comment on this?

Yes I agree, this is what you call a long haul! All I can say is that they have continuously managed to raise significant funds on a number of occasions so I still have faith in the product. I can't believe that they would have funding if this magnitude based on a punt!! I believe that we will see value but not likely until 2020. I think that will go for direct selling of the nebuliser option being "fast tracked" for the US market. We all know that this could easily 10bag eventually but I am very concerned about how much more shareholder dilution will take place en-route. Happy Xmas to you Rhodi, Izstar and all long suffering holders. Good things can happen - IMM for example.

Ok so what was everyone expecting here? Next news due Q4 and major news next year? Or am I missing something ? No different to history, old money from 20p down to 1p but science never changed. BUT as years and years and years have rolled on, I agree that we have only ever seen more expense and dilution. So we either have major investors who are all mugs like us with Directors who are the best salesman ever, OR all is WIP and patience is required, without being concerned about MM's trying to create a market or encouraging sales from frustrated investors to only allow more patient ones to pick up cheap shares. Just my take, with no opinion.

Rhodi, a lot of costs involved in the Nasdaq listing as well as fund raising costs. I have not read the report yet, but will do and will post my thoughts. Best regards to you and Izstar. This is one hell of a long haul !

It's always been known 2018 is an important year. Many options were extended to 2018. No concerns for me here, in terms of progress and timing. Just Mm's trying to make money. The Nasdaq listing was probably a condition required by the US II's. Why would anything have changed since the massive global and US capital raise? Nothing !